Sorrento Therapeutics Inc (SRNE)

[dia76ca]

YES Sorrento had 12 IND's in 2020 and it looks like at least 14 more are coming in 2021. So where is the money coming from to advance the pipeline?

I agree with those who see COVI-STIX and COVI-MSC as EUA candidates and possible revenue earners reasonably soon. But we should recall that there are 6 more potential EUA candidates lined up behind them. That's a lot of potential revenue and partnerships!

But any time Sorrento needs cash they can sell their shares in IBRX for $300+ million and/or their shares in Celularity for $400+ million. And most observers agree that PSS will be handing over some $1.2 Billion in a few months.

And next year there will be billions in revenue from SP-102, RTX and possibly Abivirtinib in cancer and cytokine storm.

Do I worry that Sorrento needs cash? NO.
Do I expect Sorrento will receive some some unsolicited buyout offers? YES.